We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $983.7 million, implying a marginal gain of 0.1% from the year-ago quarter’s reported figure. The consensus mark for earnings per share (EPS) is pegged at $1.59, indicating a 52.9% year-over-year increase. The estimate for the bottom line has improved 1 cent in the past 60 days.
For first-quarter fiscal 2025, the company expects revenues to be between $960 million and $1 billion. Non-GAAP EPS is expected to be in the range of $1.52-$1.67.
The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters and missed once, delivering an average surprise of 10.3%.
Factors at Play for PLXS
Continued demand weakness in the industrial market sector and the EMEA region remains concerning for Plexus in the near term. These factors are expected to have affected sequential revenue growth in the fiscal first quarter. Uncertainty prevailing over global macroeconomic conditions, geopolitical headwinds, customer concentration risks, stiff rivalry and supply-chain challenges remain additional concerns.
Segment-wise, management expects Aerospace/Defense to sequentially decline in the high single digits in the fiscal first quarter, mainly due to weakness in the commercial aerospace subsector offsetting strong performance in the space subsector.
Healthcare/Life Sciences sector is anticipated to decline in the high single digits, due to some continued inventory corrections and the pulling forward of activity in the fourth quarter of fiscal 2024.
Revenues are expected to decline in mid-single digits for Industrial sector, owing to demand instability across several subsectors offsetting gains in the semiconductor capital equipment vertical.
We expect revenues from Aerospace/Defense unit to be $168.4 million, up 0.8% year over year. Revenues from Healthcare/Life Sciences and Industrial sectors are expected to be $383.6 million (up 0.7% year over year) and $430.4 million (down 1% year over year).
Nonetheless, Plexus’s performance is likely to have been cushioned by new manufacturing program wins. It ended fiscal 2024 with manufacturing program wins exceeding $1 billion, including $568 million from Healthcare/Life Sciences sector. The funnel of qualified manufacturing opportunities is pegged at $3.5 billion, indicating a strong pipeline for growth. The company expects this positive demand trend to be a key catalyst in the quarter’s performance.
What Does Our Model Say for PLXS
Our proven model does not conclusively predict an earnings beat for Plexus this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, this is not the case here.
Earnings ESP: Plexus has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Plexus currently carries a Zacks Rank #3.
Stocks to Consider
Here are some stocks you may consider, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
VFC is scheduled to report quarterly earnings on Jan. 29. The Zacks Consensus Estimate for VFC’s to-be-reported quarter’s earnings and revenues is pegged at 34 cents per share and $2.75 billion, respectively. Shares of VFC have gained 43.6% in the past year.
Packaging Corporation of America (PKG - Free Report) presently has an Earnings ESP of +0.96% and a Zacks Rank #2. PKG is scheduled to report quarterly numbers on Jan. 28. The Zacks Consensus Estimate for PKG’s to-be-reported quarter’s earnings and revenues is pegged at $2.51 per share and $2.13 billion, respectively. Shares of PKG have risen 44% in the past year.
American Airlines Group Inc. (AAL - Free Report) has an Earnings ESP of +3.99% and a Zacks Rank #1 at present. AAL is scheduled to report quarterly figures on Jan. 23. The Zacks Consensus Estimate for AAL’s to-be-reported quarter’s earnings and revenues is pegged at 64 cents per share and $13.42 billion, respectively. Shares of AAL have increased 34.2% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Plexus Gearing Up to Report Q1 Earnings: What's in the Cards?
Plexus Corp (PLXS - Free Report) is slated to report first-quarter fiscal 2025 earnings on Jan. 22, after closing bell.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at $983.7 million, implying a marginal gain of 0.1% from the year-ago quarter’s reported figure. The consensus mark for earnings per share (EPS) is pegged at $1.59, indicating a 52.9% year-over-year increase. The estimate for the bottom line has improved 1 cent in the past 60 days.
For first-quarter fiscal 2025, the company expects revenues to be between $960 million and $1 billion. Non-GAAP EPS is expected to be in the range of $1.52-$1.67.
The company’s earnings beat the Zacks Consensus Estimate in three of the last four quarters and missed once, delivering an average surprise of 10.3%.
Factors at Play for PLXS
Continued demand weakness in the industrial market sector and the EMEA region remains concerning for Plexus in the near term. These factors are expected to have affected sequential revenue growth in the fiscal first quarter. Uncertainty prevailing over global macroeconomic conditions, geopolitical headwinds, customer concentration risks, stiff rivalry and supply-chain challenges remain additional concerns.
Segment-wise, management expects Aerospace/Defense to sequentially decline in the high single digits in the fiscal first quarter, mainly due to weakness in the commercial aerospace subsector offsetting strong performance in the space subsector.
Healthcare/Life Sciences sector is anticipated to decline in the high single digits, due to some continued inventory corrections and the pulling forward of activity in the fourth quarter of fiscal 2024.
Revenues are expected to decline in mid-single digits for Industrial sector, owing to demand instability across several subsectors offsetting gains in the semiconductor capital equipment vertical.
Plexus Corp. Price and EPS Surprise
Plexus Corp. price-eps-surprise | Plexus Corp. Quote
We expect revenues from Aerospace/Defense unit to be $168.4 million, up 0.8% year over year. Revenues from Healthcare/Life Sciences and Industrial sectors are expected to be $383.6 million (up 0.7% year over year) and $430.4 million (down 1% year over year).
Nonetheless, Plexus’s performance is likely to have been cushioned by new manufacturing program wins. It ended fiscal 2024 with manufacturing program wins exceeding $1 billion, including $568 million from Healthcare/Life Sciences sector. The funnel of qualified manufacturing opportunities is pegged at $3.5 billion, indicating a strong pipeline for growth. The company expects this positive demand trend to be a key catalyst in the quarter’s performance.
What Does Our Model Say for PLXS
Our proven model does not conclusively predict an earnings beat for Plexus this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, this is not the case here.
Earnings ESP: Plexus has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Zacks Rank: Plexus currently carries a Zacks Rank #3.
Stocks to Consider
Here are some stocks you may consider, as our model shows that these have the right combination of elements to beat on earnings this reporting cycle.
V.F. Corporation (VFC - Free Report) currently has an Earnings ESP of +4.30% and a Zacks Rank #1. You can see the complete list of today’s Zacks #1 Rank stocks here.
VFC is scheduled to report quarterly earnings on Jan. 29. The Zacks Consensus Estimate for VFC’s to-be-reported quarter’s earnings and revenues is pegged at 34 cents per share and $2.75 billion, respectively. Shares of VFC have gained 43.6% in the past year.
Packaging Corporation of America (PKG - Free Report) presently has an Earnings ESP of +0.96% and a Zacks Rank #2. PKG is scheduled to report quarterly numbers on Jan. 28. The Zacks Consensus Estimate for PKG’s to-be-reported quarter’s earnings and revenues is pegged at $2.51 per share and $2.13 billion, respectively. Shares of PKG have risen 44% in the past year.
American Airlines Group Inc. (AAL - Free Report) has an Earnings ESP of +3.99% and a Zacks Rank #1 at present. AAL is scheduled to report quarterly figures on Jan. 23. The Zacks Consensus Estimate for AAL’s to-be-reported quarter’s earnings and revenues is pegged at 64 cents per share and $13.42 billion, respectively. Shares of AAL have increased 34.2% in the past year.